4/A//SEC Filing
Bermingham Nessan 4/A
Accession 0001209191-21-053233
CIK 0001566373other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 6:34 PM ET
Size
5.8 KB
Accession
0001209191-21-053233
Insider Transaction Report
Form 4/AAmended
Bermingham Nessan
Director
Transactions
- Award
Common Stock
2020-11-20+16,875→ 16,875 total
Footnotes (2)
- [F1]This amendment to the Form 4 filed on November 24, 2020 is being filed solely to report the ownership of the restricted stock units ("RSUs") received by the Reporting Person in Table I of this Form 4 rather than in Table II as originally reported. No additional grants of securities are reported hereby.
- [F2]The securities awarded are in the form of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five per cent (25%) of the total number of shares under the award shall vest on the first anniversary of the "Vesting Commencement Date," July 1, 2020, and two and one twelfth per cent (2.083%) of the total number of shares under the award shall vest monthly thereafter, provided in each case that the Reporting Person remains a service provider of the Issuer continuously from the Vesting Commencement Date to the relevant date.
Documents
Issuer
F-star Therapeutics, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001377759
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 6:34 PM ET
- Size
- 5.8 KB